U.S.-based Pfizer Inc. says it has resolved U.S. Department of Justice and Securities and Exchange Commission matters related to certain improper payments in the operations of two of its subsidiaries.....
Subscribe for Full Access!
Gain valuable sourcing and trade intelligence from our database of millions of data points spanning 20+ years!
